drugset / Trial / NCT00981968

Phase 1, Single and Multiple Doses Study of Sitaxentan in Japanese and Western Subjects

NCT00981968

Phase 1 Completed 22 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate safety, tolerability and pharmacokinetics of sitaxentan following single and multiple oral administrations of sitaxentan sodium in Japanese healthy subjects.

Timeline

Start
2009-09
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitaxentan Small molecule 100 mg Oral
Subject Sitaxentan Small molecule 200 mg Oral

Indications

No indication recorded.